^
    Apply
    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*) (NCT04020575)
    Phase 1
    Minerva Biotechnologies Corporation
    Recruiting
    Last update posted :
    06/16/2023
    Initiation :
    01/15/2020
    Primary completion :
    01/01/2025
    Completion :
    01/15/2035
    HER-2 • PGR • MUC1
    |
    HER-2 positive • HR positive • HER-2 negative • HR negative • ER negative • MUC1 expression • HR positive + HER-2 negative
    |
    huMNC2-CAR22 • huMNC2-CAR44 CAR T cells